A review of cord blood concentrations of iron status parameters to define reference ranges for preterm infants

Neonatology

Volumn 104, Issue 3, 2013, Pages 194-202

  Lorenz, Laila ^a   Peter, Andreas ^b   Poets, Christian F ^a   Franz, Axel R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cord blood; Hemoglobin; Hepcidin; Iron deficiency; Mean corpuscular volume; Premature infant; Reticulocyte hemoglobin content; Soluble transferrin receptor; Transferrin saturation; Zinc protoporphyrin heme ratio

Indexed keywords

FERRITIN; HEME; HEMOGLOBIN; HEPCIDIN; IRON; PROTOPORPHYRIN ZINC; TRANSFERRIN; TRANSFERRIN RECEPTOR;

COMPARATIVE STUDY; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; IRON BLOOD LEVEL; IRON THERAPY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PREMATURITY; PRIORITY JOURNAL; REFERENCE VALUE; RETICULOCYTE HEMOGLOBIN CONTENT; REVIEW; TRANSFERRIN BLOOD LEVEL; UMBILICAL CORD BLOOD;

ANEMIA, IRON-DEFICIENCY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; REFERENCE VALUES;

EID: 84884997278     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000353161     Document Type: Review

References (75)

1. Rao R, Georgieff MK: Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med 2007; 12: 54-63.
2. Haga P: Plasma ferritin concentrations in preterm infants in cord blood and during the early anaemia of prematurity. Acta Paediatr Scand 1980; 69: 637-641.
3. Widdowson EM, Spray CM: Chemical development in utero. Arch Dis Child 1951; 26: 205-214.
4. Niklasson A, Engstrom E, Hard AL, Wikland KA, Hellstrom A: Growth in very preterm children: a longitudinal study. Pediatr Res 2003; 54: 899-905.
5. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK: Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 2005; 115: 1299-1306.
6. Grantham-McGregor S, Ani C: A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001; 131: 649S-666S, discussion 666S-668S.
7. Lozoff B, Georgieff MK: Iron deficiency and brain development. Semin Pediatr Neurol 2006; 13: 158-165.
8. Armony-Sivan R, Eidelman AI, Lanir A, Sredni D, Yehuda S: Iron status and neurobehavioral development of premature infants. J Perinatol 2004; 24: 757-762.
9. Siimes MA, Addiego JE Jr, Dallman PR: Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood 1974; 43: 581-590.
10. Franz AR, Mihatsch WA, Sander S, Kron M, Pohlandt F: Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams. Pediatrics 2000; 106: 700-706.
11. Steinmacher J, Pohlandt F, Bode H, Sander S, Kron M, Franz AR: Randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1,301 g: neurocognitive development at 5.3 years' corrected age. Pediatrics 2007; 120: 538-546.
12. McDonald MC, Abrams SA, Schanler RJ: Iron absorption and red blood cell incorporation in premature infants fed an iron-fortified infant formula. Pediatr Res 1998; 44: 507-511.
13. Widness JA, Serfass RE, Haiden N, Nelson SE, Lombard KA, Pollak A: Erythrocyte iron incorporation but not absorption is increased by intravenous iron administration in erythropoietin-treated premature infants. J Nutr 2006; 136: 1868-1873.
14. Sullivan JL: Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'. Am J Dis Child 1988; 142: 1341-1344.
15. Friel JK, Aziz K, Andrews WL, Serfass RE: Iron absorption and oxidant stress during erythropoietin therapy in very low birth weight premature infants: a cohort study. BMC Pediatr 2005; 5: 29.
16. Miller SM, McPherson RJ, Juul SE: Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr 2006; 148: 44-48.
17. Braekke K, Bechensteen AG, Halvorsen BL, Blomhoff R, Haaland K, Staff AC: Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants. J Pediatr 2007; 151: 23-28.
18. Idjradinata P, Watkins WE, Pollitt E: Adverse effect of iron supplementation on weight gain of iron-replete young children. Lancet 1994; 343: 1252-1254.
19. Dewey KG, Domellof M, Cohen RJ, Landa Rivera L, Hernell O, Lonnerdal B: Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. J Nutr 2002; 132: 3249-3255.
20. Berglund S, Westrup B, Domellof M: Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 2010; 126:e874-e883.
21. Baker RD, Greer FR: Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126: 1040-1050.
22. Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domellof M, Embleton ND, Fusch C, Genzel-Boroviczeny O, Goulet O, Kalhan SC, Kolacek S, Koletzko B, Lapillonne A, Mihatsch W, Moreno L, Neu J, Poindexter B, Puntis J, Putet G, Rigo J, Riskin A, Salle B, Sauer P, Shamir R, Szajewska H, Thureen P, Turck D, van Goudoever JB, Ziegler EE: Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010; 50: 85-91.
23. Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, Grummer-Strawn LM: Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 2005; 135: 1974-1980.
24. Thomas L: Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, ed 7. Frankfurt/ Main, TH-Books, 2008.
25. Sweet DG, Savage GA, Tubman R, Lappin TR, Halliday HL: Cord blood transferrin receptors to assess fetal iron status. Arch Dis Child Fetal Neonatal Ed 2001; 85:F46-F48.
26. Sweet DG, Savage G, Tubman TR, Lappin TR, Halliday HL: Study of maternal influences on fetal iron status at term using cord blood transferrin receptors. Arch Dis Child Fetal Neonatal Ed 2001; 84:F40-F43.
27. Ervasti M, Kotisaari S, Sankilampi U, Heinonen S, Punnonen K: The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns. Clin Chem Lab Med 2007; 45: 1000-1003.
28. Ervasti M, Sankilampi U, Heinonen S, Punnonen K: Novel red cell indices indicating reduced availability of iron are associated with high erythropoietin concentration and low ph level in the venous cord blood of newborns. Pediatr Res 2008; 64: 135-140.
29. Ervasti M, Sankilampi U, Heinonen S, Punnonen K: Early signs of maternal iron deficiency do not influence the iron status of the newborn, but are associated with higher infant birthweight. Acta Obstet Gynecol Scand 2009; 88: 83-90.
30. Noguera NI, Detarsio G, Perez SM, Bragos IM, Lanza O, Rodriguez JH, Acosta I, Davoli R, Milani AC: Hematologic study of newborn umbilical cord blood. Medicina (B Aires) 1999; 59: 446-448.
31. Choi JW, Kim CS, Pai SH: Erythropoietic activity and soluble transferrin receptor level in neonates and maternal blood. Acta Paediatr 2000; 89: 675-679.
32. Mukhopadhyay K, Yadav RK, Kishore SS, Garewal G, Jain V, Narang A: Iron status at birth and at 4 weeks in preterm-SGA infants in comparison with preterm and term-AGA infants. J Matern Fetal Neonatal Med 2012; 25: 1474-1478.
33. Verner AM, Manderson J, Lappin TR, Mc-Cance DR, Halliday HL, Sweet DG: Influence of maternal diabetes mellitus on fetal iron status. Arch Dis Child Fetal Neonatal Ed 2007; 92:F399-F401.
34. Bradley J, Leibold EA, Harris ZL, Wobken JD, Clarke S, Zumbrennen KB, Eisenstein RS, Georgieff MK: Influence of gestational age and fetal iron status on IRP activity and iron transporter protein expression in third-trimester human placenta. Am J Physiol Regul Integr Comp Physiol 2004; 287:R894-R901.
35. Zaizov R, Matoth Y: Red cell values on the first postnatal day during the last 16 weeks of gestation. Am J Hematol 1976; 1: 275-278.
36. Forestier F, Daffos F, Galacteros F, Bardakjian J, Rainaut M, Beuzard Y: Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20: 342-346.
37. Burman D, Morris AF: Cord haemoglobin in low birthweight infants. Arch Dis Child 1974; 49: 382-385.
38. Rios E, Lipschitz DA, Cook JD, Smith NJ: Relationship of maternal and infant iron stores as assessed by determination of plasma ferritin. Pediatrics 1975; 55: 694-699.
39. Alur P, Devapatla SS, Super DM, Danish E, Stern T, Inagandla R, Moore JJ: Impact of race and gestational age on red blood cell indices in very low birth weight infants. Pediatrics 2000; 106: 306-310.
40. Kleven KJ, Blohowiak SE, Kling PJ: Zinc protoporphyrin/ heme in large-for-gestation newborns. Neonatology 2007; 92: 91-95.
41. Lott DG, Zimmerman MB, Labbe RF, Kling PJ, Widness JA: Erythrocyte zinc protoporphyrin is elevated with prematurity and fetal hypoxemia. Pediatrics 2005; 116: 414-422.
42. Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK: The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 2007; 92: 73-82.
43. Hay G, Refsum H, Whitelaw A, Melbye EL, Haug E, Borch-Iohnsen B: Predictors of serum ferritin and serum soluble transferrin receptor in newborns and their associations with iron status during the first 2 years of life. Am J Clin Nutr 2007; 86: 64-73.
44. Young MF, Pressman E, Foehr ML, McNanley T, Cooper E, Guillet R, Orlando M, McIntyre AW, Lafond J, O'Brien KO: Impact of maternal and neonatal iron status on placental transferrin receptor expression in pregnant adolescents. Placenta 2010; 31: 1010-1014.
45. Rehu M, Punnonen K, Ostland V, Heinonen S, Westerman M, Pulkki K, Sankilampi U: Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol 2010; 85: 345-352.
46. Young MF, Griffin I, Pressman E, McIntyre AW, Cooper E, McNanley T, Harris ZL, Westerman M, O'Brien KO: Maternal hepcidin is associated with placental transfer of iron derived from dietary heme and nonheme sources. J Nutr 2012; 142: 33-39.
47. Shao J, Lou J, Rao R, Georgieff MK, Kaciroti N, Felt BT, Zhao ZY, Lozoff B: Maternal serum ferritin concentration is positively associated with newborn iron stores in women with low ferritin status in late pregnancy. J Nutr 2012; 142: 2004-2009.
48. Kuiper-Kramer EP, Baerts W, Bakker R, van Eyck J, van Raan J, van Eijk HG: Evaluation of the iron status of the newborn by soluble transferrin receptors in serum. Clin Chem Lab Med 1998; 36: 17-21.
49. Suominen P, Punnonen K, Rajamaki A, Irjala K: Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998; 92: 2934-2939.
50. Juul SE, Zerzan JC, Strandjord TP, Woodrum DE: Zinc protoporphyrin/heme as an indicator of iron status in NICU patients. J Pediatr 2003; 142: 273-278.
51. Kling PJ: The zinc protoporphyrin/heme ratio in premature infants: has it found its place? J Pediatr 2006; 148: 8-10.
52. Lesser KB, Schoel SB, Kling PJ: Elevated zinc protoporphyrin/heme ratios in umbilical cord blood after diabetic pregnancy. J Perinatol 2006; 26: 671-676.
53. Cheng CF, Zerzan JC, Johnson DB, Juul SE: Zinc protoporphyrin-to-heme ratios in highrisk and preterm infants. J Pediatr 2012; 161: 81-7.e1.
54. Baumann-Blackmore NL, Goetz E, Blohowiak SE, Zaka O, Kling PJ: Cord blood zinc protoporphyrin/ heme ratio in minority neonates at risk for iron deficiency. J Pediatr 2008; 153: 133-136.
55. Labbe RF: Zinc protoporphyrin/heme ratio as an indicator of marrow iron stores. Am J Clin Pathol 1991; 95: 758.
56. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M: Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297.
57. Bratteby LE, Garby L, Groth T, Schneider W, Wadman B: Studies on erythro-kinetics in infancy. 13. The mean life span and the life span frequency function of red blood cells formed during foetal life. Acta Paediatr Scand 1968; 57: 311-320.
58. Oh W, Lind J: Venous and capillary hematocrit in newborn infants and placental transfusion. Acta Paediatr Scand 1966; 55: 38-48.
59. Olivieri NF: Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and child. Semin Perinatol 1997; 21: 63-69.
60. Jacobs A: Ferritin: an interim review. Curr Top Hematol 1985; 5: 25-62.
61. Kohgo Y, Niitsu Y, Kondo H, Kato J, Tsushima N, Sasaki K, Hirayama M, Numata T, Nishisato T, Urushizaki I: Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70: 1955-1958.
62. Krallis N, Cholevas V, Mavridis A, Georgiou I, Bourantas K, Andronikou S: Effect of recombinant human erythropoietin in preterm infants. Eur J Haematol 1999; 63: 71-76.
63. Akesson A, Bjellerup P, Vahter M: Evaluation of kits for measurement of the soluble transferrin receptor. Scand J Clin Lab Invest 1999; 59: 77-81.
64. Szoke D, Panteghini M: Diagnostic value of transferrin. Clin Chim Acta 2012; 413: 1184-1189.
65. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R: Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem 1992; 38: 2184-2189.
66. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R: Zinc protoporphyrin in anemia of chronic disorders. Blood 1993; 81: 1200-1204.
67. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O: Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994; 83: 3100-3101.
68. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276.
69. Muller KF, Lorenz L, Poets CF, Westerman M, Franz AR: Hepcidin concentrations in serum and urine correlate with iron homeostasis in preterm infants. J Pediatr 2012; 160: 949-953.e2.
70. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044.
71. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW: Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009; 94: 1748-1752.
72. Domellof M: Iron requirements in infancy. Ann Nutr Metab 2011; 59: 59-63.
73. Brown MS: Effect of transfusion and phlebotomy on serum ferritin levels in low birth weight infants. J Perinatol 1996; 16: 39-42.
74. Kasper DC, Widness JA, Haiden N, Berger A, Hayde M, Pollak A, Herkner KR: Characterization and differentiation of iron status in anemic very low birth weight infants using a diagnostic nomogram. Neonatology 2009; 95: 164-171.
75. Obladen M, Sachsenweger M, Stahnke M: Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 1988; 147: 399-404.